Shopping Cart
- Remove All
- Your shopping cart is currently empty
Pacanalotamab (AMG 420; BI-836909) is a bispecific T-cell engager (BiTE) that specifically targets BCMA (B cell maturation antigen) and CD3ɛ. By redirecting T cells to cells expressing BCMA, Pacanalotamab facilitates the T-cell mediated lysis of human multiple myeloma (MM) cell lines [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $498 | 2-4 weeks | |
5 mg | $1,230 | 2-4 weeks | |
10 mg | $1,990 | 2-4 weeks |
Description | Pacanalotamab (AMG 420; BI-836909) is a bispecific T-cell engager (BiTE) that specifically targets BCMA (B cell maturation antigen) and CD3ɛ. By redirecting T cells to cells expressing BCMA, Pacanalotamab facilitates the T-cell mediated lysis of human multiple myeloma (MM) cell lines [1]. |
Cas No. | 2251756-52-0 |
Storage | store at -80°C | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.